AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy
Journal of Medical Internet Research · 09.07.2026 · 28 · e106201-e106201
DOI: 10.2196/106201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 09.07.2026. Verfasst von Benedette Cuffari. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Precision Medicine, Neoplasms, Machine Learning. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Computing advances are helping improve the precision and effectiveness of cancer treatment. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent AI applications for radiopharmaceutical therapy, as well as the current state of the field and its future potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Cuffari, B. (2026). AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. Journal of Medical Internet Research, 28, e106201-e106201. https://doi.org/10.2196/106201
Vancouver
Cuffari B. AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. Journal of Medical Internet Research. 2026;28:e106201-e106201. doi:10.2196/106201
BibTeX
@article{Cuffari2026,
author = {Cuffari, Benedette},
title = {AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e106201--e106201},
doi = {10.2196/106201}
}
EUVIMED